Mark Beck
IDEX CORP /DE/About Mark Beck
Mark A. Beck, age 59, has served on IDEX’s Board for approximately 7.3 years and is an independent director. He co-founded and owns B‑Square Precision, LLC (2018–present), and previously was President & CEO of JELD‑WEN Holding, Inc. (Nov 2015–Feb 2018), EVP at Danaher (from Apr 2014), and held senior leadership roles at Corning culminating as EVP over Environmental Technologies and Life Sciences in July 2012; he also served on Dow‑Corning’s board (2010–2014). He holds a BA in Business Management from Pacific University and an MBA from Harvard University.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| B‑Square Precision, LLC | Co‑founder & Owner | 2018–present | Acquires/manages precision tooling businesses; operating experience across industrial manufacturing |
| JELD‑WEN Holding, Inc. | President & CEO; Director | Nov 2015–Feb 2018; May 2016–Feb 2018 | Led global door/window manufacturer; board service |
| Danaher Corporation | Executive Vice President (Water Quality & Dental platforms) | From Apr 2014 | Led diversified platforms; M&A and integration experience |
| Corning Incorporated | Executive Vice President (Environmental Technologies & Life Sciences) | From Jul 2012 (prior 18 years in roles of increasing responsibility) | Oversaw major business units; innovation/operations |
| Dow‑Corning Corporation | Director | 2010–2014 | Board oversight at JV/industry leader |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Owens & Minor, Inc. (public) | Chairman of the Board | Current | Board leadership; healthcare supply chain oversight |
| kdc/one (private) | Director | Current | Manufacturing and consumer products exposure |
Board Governance
- Independence: Board affirmatively determined Beck is independent under NYSE standards; all standing committees are fully independent.
- Committees: Compensation Committee member; Nominating & Corporate Governance Committee Chair.
- Attendance/Engagement: Board held 8 meetings in 2024; each director attended >75% of aggregate Board/committee meetings; all directors attended the 2024 annual meeting.
- Executive sessions: Independent non‑management directors met separately at every regularly scheduled Board meeting; Non‑Executive Chair presided in 2024.
- Compensation Committee practices: Uses independent consultant F.W. Cook; no conflicts identified; six meetings in 2024.
- Nominating & Corporate Governance Committee practices: Oversight of governance and sustainability; five meetings in 2024.
- Related parties: Audit Committee administers Related Person Transactions policy; no related person transactions requiring disclosure since Jan 1, 2024.
Fixed Compensation
| Component | 2024 Amount | Details |
|---|---|---|
| Annual Cash Retainer | $95,000 | Retainer increased by $5,000 for 2024 to align with market |
| Committee Chair Retainer (NCGC) | $15,000 | Nominating & Corporate Governance Committee chair fee |
| Total Fees Earned (Beck) | $110,000 | Cash fees reported for 2024 |
| Director Deferred Compensation Plan | — | Directors may defer cash fees; investment choices include interest index or mutual funds; unfunded, unsecured obligations |
| Stock Ownership Guideline | 5× annual Board service retainer | Mandatory holding until guideline met; all non‑management directors in compliance or subject to holding requirement |
Performance Compensation
| Equity Component | 2024/2025 Grants | Vesting/Key Terms |
|---|---|---|
| Annual Equity Grant (Directors) | $165,000 grant date fair value (100% RSUs) | RSUs vest at the earlier of 1 year or next annual meeting (≥50 weeks), or upon death/disability, failure to be re‑elected, or change in control; RSUs non‑transferable until no longer serving; settlement may be deferred by director |
| Beck RSU Grant (May 7, 2024) | 745 RSUs (Form 4) | Grant on May 7, 2024; vests May 7, 2025; post‑transaction ownership 6,055 shares |
| Beck RSU Grant (May 8, 2025) | 895 RSUs (Form 4) | Grant on May 8, 2025; post‑transaction ownership 6,950 shares |
Note: IDEX does not use performance metrics for director equity; director RSUs are time‑based awards with prescribed vesting and change‑in‑control terms.
Other Directorships & Interlocks
| Company | Relationship to IDEX | Potential Interlock/Conflict Considerations |
|---|---|---|
| Owens & Minor, Inc. | Healthcare supply chain distributor; IDEX is diversified industrial components | Board determined Beck independent after reviewing organizational relationships; no related person transactions disclosed |
| kdc/one | Private manufacturer serving beauty/consumer brands | No related person transactions disclosed; independence affirmed |
| JELD‑WEN (prior) | Building products; prior CEO and director | Historical role; no current related transactions reported |
| Dow‑Corning (prior) | Materials JV; prior director | Historical role; no current related transactions reported |
Expertise & Qualifications
- Industrial leadership: Former public‑company CEO (JELD‑WEN); EVP roles at Danaher and Corning; track record in integrating acquisitions and driving innovation.
- Board skills matrix: High financial literacy; “Audit Committee Financial Expert” designation present on board (not specified for Beck); deep senior leadership, international manufacturing, M&A competencies; tenure 7.3 years; age 59.
- Education: BA, Pacific University; MBA, Harvard University.
Equity Ownership
| Holder | Shares Beneficially Owned | Percent of Class | Notes |
|---|---|---|---|
| Mark A. Beck | 6,055 | <1% | As of record date Mar 13, 2025; includes RSUs (some vested with deferred settlement); director RSU grants and deferrals detailed in footnotes |
| Post‑Form 4 (May 8, 2025) | 6,950 | <1% | Reflects RSU award per Form 4; Director hedging/pledging prohibited under insider trading policy |
Selected RSU grant and vesting schedule for Beck:
| Grant Date | RSUs | Vest Date | Settlement Election |
|---|---|---|---|
| Jan 2, 2018 | 310 | Standard annual vest | Deferred settlement elected |
| Apr 25, 2018 | 945 | Standard annual vest | Deferred settlement elected |
| May 10, 2019 | 845 | Standard annual vest | Deferred settlement elected |
| May 7, 2020 | 950 | Standard annual vest | Deferred settlement elected |
| May 12, 2021 | 665 | Standard annual vest | Deferred settlement elected |
| May 6, 2022 | 825 | May 6, 2025 | Deferred settlement elected |
| May 25, 2023 | 770 | May 25, 2026 | Deferred settlement elected |
| May 7, 2024 | 745 | May 7, 2025 | Annual grant |
| May 8, 2025 | 895 | One‑year vest per policy | Annual grant (Form 4) |
Insider Trades (Form 4)
| Filing Date | Transaction Date | Type | Shares Transacted | Post‑Transaction Ownership | Link |
|---|---|---|---|---|---|
| 2024‑05‑08 | 2024‑05‑07 | A – Award (RSUs) | 745 | 6,055 | https://www.sec.gov/Archives/edgar/data/832101/000083210124000019/0000832101-24-000019-index.htm |
| 2025‑05‑12 | 2025‑05‑08 | A – Award (RSUs) | 895 | 6,950 | https://www.sec.gov/Archives/edgar/data/832101/000090514825001581/0000905148-25-001581-index.htm |
Governance Assessment
- Board effectiveness: Beck’s dual service as NCGC Chair and Compensation Committee member positions him at the center of governance and pay oversight; committees held five and six meetings respectively in 2024, indicating active engagement.
- Independence & attendance: Independence affirmed; attendance exceeded 75% threshold; consistent presence in executive sessions strengthens independent oversight.
- Director pay mix & alignment: 2024 compensation comprised $110,000 cash fees and $165,000 RSUs; director stock ownership guideline (5× retainer) and deferred settlement elections indicate long‑term alignment; hedging/pledging prohibited.
- Market benchmarking & inflation risk: Board increased cash retainer by $5,000 and equity grant by $10,000 in 2024 to align at median versus peers; Compensation Committee engages independent consultant with no conflicts.
- Conflicts/related parties: No related person transactions disclosed since Jan 1, 2024; Audit Committee administers related‑party policy.
RED FLAGS
- None disclosed: no related‑party transactions, no hedging/pledging, and independence affirmed.
Additional investor signals
- Say‑on‑pay support: >91% approval in 2024 suggests shareholder confidence in compensation governance framework.